Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Wasatch Ultra Growth Fund (WAMCX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital; income is a secondary consideration. The fund invests primarily in smaller high growth companies. It will invest the fund's assets in the equity securities of companies which the managers consider to be rapidly growing. The fund may invest up to 30% of its total assets at the time of purchase in securities issued by foreign companies in developed or emerging markets. It may invest a large percentage of its assets in a few sectors, including consumer discretionary, financials, health care, industrials and information technology. It may invest in initial public offerings (IPOs).


1 month+5.78% 3 years+13.31%
3 months+4.02% 5 years+13.59%
1 year+18.23% Since inception+10.28%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+13.59%+12.81%
Expense ratio1.43%1.29%
Risk 5 year sharpe ratio0.940.92
Net assets$106.2M$944.4M
Average market cap$1.4B$3.5B
Average P/E33.029.9
Portfolio turnover28%28%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyWasatch
Fund manager & tenureJohn Malooly / 5 Years
Minimal initial investment$2,000.00
Minimum IRA investment$2,000.00


U.S. stock82.33%
International stock10.63%
Fixed income5.95%
Top 5 Sectors
Portfolio weighting
Hardware 20.28%
Healthcare 13.40%
Business service 11.02%
Financial service 10.44%
Consumer service 7.36%
Top 10 Holdings
Portfolio weighting
FRPT Freshpet Inc3.28%
ULTI Ultimate Software Group Inc3.17%
OXFD Oxford Immunotec Global PLC2.73%
-- 2.46%
PCTY Paylocity Holding Corp2.43%
ATRC AtriCure Inc2.39%
LGIH LGI Homes Inc2.33%
SGMO Sangamo Therapeutics Inc2.23%
PDFS PDF Solutions Inc2.18%
ZEN Zendesk Inc2.04%